1 |
Blepharospasm and hemifacial spasm: Long-term treatment with botulinum toxin [Blefarospasmo y espasmo hemifacial: Tratamiento a largo plazo con toxina botulínica] |
|
|
| Gil Polo, C. and Rodríguez Sanz, M.F. and Berrocal Izquierdo, N. and Castrillo Sanz, A. and Gutiérrez Ríos, R. and Zamora García, M.I. and Mendoza Rodríguez, A. and Duarte García-Luis, J. |
|
| Neurologia. 2013; 28(3): 131-136 |
|
| [Pubmed] [Google Scholar] |
|
2 |
Effects of botulinum toxin type a on quality of life assessed with the WHOQOL-BREF in hemifacial spasm and blepharospasm |
|
|
| Gürsoy, A.E. and Ugurad, I. and Babacan-Yildiz, G. and Kolukisa, M. and Çelebi, A. |
|
| Neurology Psychiatry and Brain Research. 2013; 19(1): 12-18 |
|
| [Pubmed] [Google Scholar] |
|
3 |
Efficacy of botulinum toxin injections in the treatment of various types of facial region disorders [Yüz bölgesi hastaliklarinin çeşitli tiplerinde botulinum toksini enjeksiyonlarinin etkinliǧi] |
|
|
| Joban, A. and Matur, Z. and Hanaǧasi, H.A. and Parman, Y. |
|
| Turk Noroloji Dergisi. 2012; 18(4): 133-161 |
|
| [Pubmed] [Google Scholar] |
|
4 |
Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia [Influência da toxina botulínica tipo A na função lacrimal de pacientes com distonias faciais] |
|
|
| de Oliveira, F.C. and de Oliveira, G.C. and Cariello, A.J. and Felberg, S. and Osaki, M.H. |
|
| Arquivos Brasileiros de Oftalmologia. 2010; 73(5): 405-408 |
|
| [Pubmed] [Google Scholar] |
|
5 |
Botulinum toxin type A in the treatment of hemifacial spasm: An 11-year experience [Toxina botulínica tipo A no tratamento do espasmo hemifacial: 11 anos de experiência] |
|
|
| Barbosa, E.R. and Takada, L.T. and Gonçalves, L.R. and Costa, R.M.P.N. and Silveira-Moriyama, L. and Chien, H.F. |
|
| Arquivos de Neuro-Psiquiatria. 2010; 68(4): 502-505 |
|
| [Pubmed] [Google Scholar] |
|
6 |
The effects of botulinum toxin a on ephaptic transmission in idiopathic hemifacial spasm |
|
|
| Kurt, T. and Seçil, Y. and Gürgör, N. and Tokuçoǧlu, F. and Beckmann, Y. and Ertekin, C. |
|
| International Journal of Neuroscience. 2009; 119(11): 2044-2055 |
|
| [Pubmed] [Google Scholar] |
|
7 |
Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: Same Toxin, Two Drugs |
|
|
| Bentivoglio, A.R. and Fasano, A. and Ialongo, T. and Soleti, F. and Lo Fermo, S. and Albanese, A. |
|
| Neurotoxicity Research. 2009; 15(3): 224-231 |
|
| [Pubmed] [Google Scholar] |
|
8 |
Relationship between various clinical outcome assessments in patients with blepharospasm |
|
|
| Jankovic, J. and Kenney, C. and Grafe, S. and Goertelmeyer, R. and Comes, G. |
|
| Movement Disorders. 2009; 24(3): 407-413 |
|
| [Pubmed] [Google Scholar] |
|
9 |
Efficacy and safety of purified botulinum toxin type A (Dysport®) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial |
|
|
| Truong, D. and Comella, C. and Fernandez, H.H. and Ondo, W.G. |
|
| Parkinsonism and Related Disorders. 2008; 14(5): 407-414 |
|
| [Pubmed] [Google Scholar] |
|
10 |
Essential blepharospasm and hemifacial spasm: Characteristic of the patient, botulinum toxin A treatment and literature review [Blefarospasmo essencial e espasmo hemifacial: Características dos pacientes, tratamento com toxina botulínica A e revisão da literatura] |
|
|
| Schellini, S.A. and Matai, O. and Igami, T.Z. and Padovani, C.R. and Padovani, C.P. |
|
| Arquivos Brasileiros de Oftalmologia. 2006; 69(1): 23-26 |
|
| [Pubmed] [Google Scholar] |
|